BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7910656)

  • 1. [Measurement of the secretion of growth hormone in patients with thalassemia major].
    De Luca G; Maggiolini M; Bria M; Caracciolo M; Lanzino M; Le Pera M; Brancati C; Andò S
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):62-5. PubMed ID: 7910656
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of thalassemia treated with conventional therapy.
    Borgna-Pignatti C; Zurlo MG; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
    Bone Marrow Transplant; 1993; 12 Suppl 1():2-4. PubMed ID: 8374554
    [No Abstract]   [Full Text] [Related]  

  • 3. Low bone mineral density in adolescents with beta-thalassemia.
    Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
    Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
    Giardini C; La Nasa G; Contu L; Galimberti M; Polchi P; Angelucci E; Baronciani D; Barbanti I; Muretto P; Lucarelli G
    Bone Marrow Transplant; 1993; 12 Suppl 1():108-10. PubMed ID: 8374548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Growth hormone deficiency dwarfism and idiopathic hypopituitarism. Study of hypothalamo-hypophyseal function].
    Martín Zurro A; Sánchez Franco F; Cerdán Vallejo A; García García MD; Cacicedo L
    Rev Clin Esp; 1973 Jul; 130(2):117-22. PubMed ID: 4582541
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
    Mangiagli A; Italia S; Campisi S
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():985-6. PubMed ID: 10091179
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of growth hormone secretion. Relevance to the pediatrician.
    Bercu BB; Diamond FB
    Pediatrician; 1987; 14(3):94-108. PubMed ID: 2899314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can provocative growth hormone testing predict the response to recombinant human growth hormone (rhGH) treatment?
    Greco M; Cappa M; Perruzza I; Rizzoni G
    Br J Clin Pract Suppl; 1996 Aug; 85():38-40. PubMed ID: 8995028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
    Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
    J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common queries in thalassemia care.
    Panigrahi I; Marwaha RK
    Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and sexual maturation in children with thalassemia major.
    Yesilipek MA; Bircan I; Oygür N; Ertug H; Yegin O; Güven AG
    Haematologica; 1993; 78(1):30-3. PubMed ID: 8491419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M; Bana M; Ahmed US; Bano S; Yousuf M; Fadoo Z; Khurshid M
    Singapore Med J; 2006 Aug; 47(8):693-6. PubMed ID: 16865210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
    Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P
    Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac study by dobutamine stress echocardiography in thalassemic patients.
    Mariotti E; Agostini A; Angelucci E; Cesaroni P; Lucarelli G; Sgarbi E
    Bone Marrow Transplant; 1993; 12 Suppl 1():14-5. PubMed ID: 8374553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and puberty in thalassemia major.
    Raiola G; Galati MC; De Sanctis V; Caruso Nicoletti M; Pintor C; De Simone M; Arcuri VM; Anastasi S
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():259-66. PubMed ID: 12729401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
    Guzzaloni G; Grugni G; Morabito F
    Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.